Abstract.-Several tissue culture cell lines that were transformed by a tumor virus have been found to react with an agglutinin, while under identical conditions their untransformed parent cell lines did not agglutinate. Since a short treatment of the parent cell line with low concentrations of proteases exposed the same agglutinin receptor sites in a fashion indistinguishable from the transformed cells, it is proposed that both viral and chemical transformation produce changes in the architecture of the membrane, identical to those of the proteases.
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An agglutinin was isolated and purified' that interacted primarily with neoplastic cells,2 N-acetyl-glucosamine was found to be an important part of the tumor cell surface receptor.' Exceptions to the tumor specificity of this agglutinin have been reported.3' 4 However, all the virally transformed cells tested so far reacted with the agglutinin,5 while the parent cells from which they were derived did not react under identical conditions, an indication that the agglutinating site appeared on the cell surface during viral transformation.
Changes in the cell surface have been postulated as the basis for some of the most typical characteristics of cancer cells, like invasive growth, metastasizing, and loss of contact inhibition.6' A similar change may be involved in the conversion of the nonagglutinable state of the common tissue culture cell to the agglutinable state of the virally transformed cell. Whether the appearance of this agglutination site is tightly linked to the appearance of the pathobiological phenomena is mere speculation at the present time. Nevertheless, this notion has found support in a good correlation between loss of contact inhibition of growth and agglutinability.8
Three possible mechanisms could account for this conversion of the surface membrane from the nonagglutinable to the agglutinable form:
(1) The parent cell may have no agglutinin receptors, and the virus may bring in new genetic information coding for the formation of this surface site or inducing the formation of this surface site de novo.
(2) The parent cell may carry a few agglutin receptor sites but not enough for agglutination to occur, and the virus would then be responsible for the formation of increased amounts of the surface receptor sites.
(3) The parent cell has virtually all agglutinin receptor sites in a cryptic form, and the tumor virus would convert the membrane in such a fashion that the agglutination site would be exposed and become available to the agglutinin.
The evidence presented here gives strong support to the third mechanism. (3) Purification of agglutinin: Large quantities (10-100 mg) of agglutinin were prepared from wheat germ lipase as described earlier.' Particularly pure agglutinin was obtained with a new technique based on the fact that we found N-acetylglucosamine (GlcNac), di-N-acetyl-chitobiose, and ovomucoid (containing mainly GlcNac in its carbohydrate moiety) to be strong hapten inhibitors of the agglutination reaction. A similar hapten elution technique was used earlier to purify antibodies against teichoic acids." Kieselguhr (13 gm) was washed with HCl, NaOH, and NaCl, suspended in a solution of 20 mg/ml ovomucoid, stirred for 1 hr, and poured into a column. The kieselguhr was saturated by pouring 20-ml portions of 20 mg/ml ovomucoid in batches over the column until no further ovomucoid could be adsorbed anymore. To release any poorly bound ovomucoid, the column was rinsed with 500 ml of 0.01 M GlcNac, the eluent used later. Chromatography of the heat-inactivated lipase is described in the legend to Figure 1 . A similar technique was described earlier by Goldberg.12 The hapten elution technique with di-N-acetyl-chitobiose yields a very pure agglutinin preparation and gives a single band on polyacrylamide disc gel electrophoresis. The purification technique described earlier' (as well as the peak around tube no. 50) yielded two bands (Fig. 2) . The procedure described here gave very poor recoveries, however.
(4) Assay of agglutination: The method was essentially the same as described earlier' except that 0.1 ml of the cell suspension of 2 X 106 cells/ml was used and the test scored with the microscope after 2, 5, and 10 min. Attempts at putting the agglutination assay on a more quantitative and biochemical basis failed.
Results.-Using a hypotonic shock procedure' we found that a particulate material from the surface of chemically induced leukemia cells as well as virally transformed cells could be isolated and that it had hapten inhibitory properties in the agglutination tests. For this and other reasons, it was concluded that this particle probably contained the surface receptor site.' A similar isolation procedure, applied to the untransformed cells, produced also an inhibitory particle which could be solubilized and which is under investigation."3 This preliminary finding suggested that the agglutination site may also be present in untransformed cells but is not available to the agglutinin. Such considerations prompted an attempt to expose the cryptic site of normal cells and thereby directly demonstrate the potential agglutinability of normal cells.
Conversion by proteases: A brief trypsin treatment'4 was found to convert normal cells from a state in which they do not respond to the agglutinin to a state in which they do. We give evidence below that this phenomenon is not only widespread among different cell lines but that apparently any protease can induce it and that the proteolytic enzyme has to be active.
(1) All nontransformed cells tested so far could be converted from a nonagglutinable to an agglutinable form. The cells tested were: BHK-D, BHK-S, BHK-Float, 3T3, primary chick embryo fibroblasts, and rat liver cells.
(2 conversion. Tested were DNase, RNase, collagenase, and some glycosidases.
The minimal concentrations necessary for conversion of 3T3 cells in six minutes are: for trypsin, 0.05 mg/ml; for chymotrypsin, 0.08 mg/ml; for ficin, 0.005 mg/ml; and for papain, 0.008 mg/ml.
(3) Proteolytic activity of the enzyme seems to be required for the conversion phenomenon: (a) heat-inactivated trypsin does not act; (b) soybean trypsin inhibitor prevents the conversion; (c) diisopropylfluorophosphate-inactivated trypsin loses its effectiveness completely.
Quantitative similarity of the receptor sites: The agglutinability of normal cells treated with proteases under optimal conditions is identical to that of the untreated, virally transformed cells. In other words the contribution to agglutination of both, the number of receptor sites for agglutinin, and the affinity for the agglutinin seem to be the same in normal protease-treated cells and in virally transformed cells. This conclusion is supported by the fact that different cells have intrinsically different agglutinabilities (e.g., 3T3 and BHK) and that protease treatment allows normal cells to reach the same state of agglutinability as each cell type acquires during transformation. This is illustrated in Figure 3, Chick embryo fibroblasts, trypsinized
Rat liver cells, trypsinized 2.0 0.4 0.018 Nontransformed cells were treated with 0.005% trypsin for 3 min, the reaction was stopped with a final concentration of 0.05% soybean inhibitor, and the cells were washed.
The inhibitor was first incubated with agglutinin at room temperature for 3 min. Then the solution containing both inhibitor and agglutinin was added to the cell suspension, and the agglutination was scored after 20 min. The agglutinin concentration in each case was chosen to be the minimal amount necessary to give + + + + agglutination in the standard assay. The numbers given are an average of four determinations. reversion are probably based on mass law principles and are not due to a toxic or metabolic interaction between the inhibitor and the cell. (4) Sialidase treatment of the protease-converted normal cells prevented agglutination, as was found for the transformed cells.1' 15 Discussion.-Three possible mechanisms are suggested which could explain the formation of an agglutinin receptor site during transformation by a tumor virus or other oncogen (Fig. 5) . Our results favor the third one. In this case the agglutinin receptor site is already present in the untransformed cell but is not available to the agglutinin; however, transformation changes the surface in such a fashion that the agglutinin can now reach its receptor site.
The first type of mechanism, i. Such a change in glycolipids of the membrane may be superimposed on the structural change in the membrane suggested here; both may exist at the same time and contribute to the increased agglutinability of the transformed cell. On the other hand, probably not all the N-acetyl-glucosamine or di-N-acetyl-chitobiose in the membrane occurs in glycolipids, for some, if not the major part, can be found in glycoproteins and mucopolysaccharides. Both of them are therefore candidates for being agglutinin receptors as much as glycolipids are. Until the agglutinin receptor(s) have been isolated in pure form, one does not know how much each component containing N-acetyl-glucosamine contributes to the agglutination property of the transformed cell.
Compositional differences between normal and tumor cells have been postulated as well as reported, but this is probably the first experimental indication that differences may occur at the level of the microstructure of the membrane. We may therefore speculate on the mechanisms of conversion from the nonagglutinable to the agglutinable membrane form: (1) proteases may remove a surface layer of protein or a layer attached by protein to the membrane and thus directly expose the agglutination site covered in the untransformed cell; (2) proteases may remove a protein sonmewhere on the surface and thereby induce a configurational change of the surface which exposes the agglutination site; or (3) proteases may just split a peptide bond on the surface and thus induce the rearrangement of the surface membrane to the agglutinable form. These questions will be examined in a later paper.
It is not too likely that a continually synthesized protease could be the sole cause for the creation and maintenance of the transformed state including all the intracellular and metabolic processes. Nevertheless, it may be possible that some of the changes that occur in the surface of the transformed cell may be due to the continuous presence of proteases, released from lysosomes or secretory vesicles to the surface. The involvement of lysosomes in the oncogenic process has already been documented.'0
